Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells

Journal of Pharmaceutical Sciences

Volumn 100, Issue 7, 2011, Pages 2724-2733

  Kaur, Randip ^a   Chen, Jili ^b   Dawoodji, Amina ^b   Cerundolo, Vincenzo ^b   Garcia Diaz, Yoel R ^c   Wojno, Justyna ^c   Cox, Liam R ^c   Besra, Gurdyal S ^c   Moghaddam, Behfar ^a   Perrie, Yvonne ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Bilayer; Cationic lipids; Dendritic cells; Invariant natural killer T cells; Liposomes; Monolayer studies; Particle size; Stability; Threitol ceramide

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CERAMIDE; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; GAMMA INTERFERON; IMMUNOSTIMULATING AGENT; LIPOSOME; THREITOL CERAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENCAPSULATION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LANGMUIR BLODGETT FILM; NATURAL KILLER T CELL;

EID: 79955612063     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22500     Document Type: Article

References (37)

1. Schmieg J, Yang G, Franck R, Van Rooijen N, Tsuji M. 2005. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc Natl Acad Sci U S A 102:1127-1132.
2. Godfrey D, Hammond K, Poulton L, Smyth M, Baxter A. 2000. NKT cells: Facts, functions and fallacies. Immunol Today 21:573-583.
3. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo Eea. 1997. CD1d-restricted and TCR-mediated activation of V9 (alpha) 14 NKT cells by glycosylceramides. Science 278:1626-1629.
4. Spada F, Borriello F, Sugita M, Watts G, Koezuka Y, Porcelli S. 2000. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur J Immunol 30:3468-3477.
5. Matsuda J, Naidenko O, Gapin L, Nakayama T, Taniguchi M, Wang C, Koezuka Y, Kronenberg M. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 192:741-753.
6. Parekh V, Lalani S, Kim S, Halder R, Azuma M, Yagita H, Kumar V, Wu L, Van Kaer L. 2009. PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. J Immunol 182:2816-2826.
7. Silk J, Salio M, Reddy B, Shepherd D, Gileadi U, Brown J, Masri S, Polzella P, Ritter G, Besra Gea. 2008. Nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells. J Immunol 180:6452-6456.
8. Bangham A, Standish M, Watkins J. 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238-252.
9. Carmona-Ribeiro A, Ortis F, Schumacher R, Armelin M. 1997. Interactions between cationic vesicles and cultured mammalian cells. Langmuir 13:2215-2218.
10. NL, Mamizuka E, Carmona-Ribeiro A. 2003. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments. J Antimicrob Chemoth 52:412-418.
11. Dzata G, Wyckoff J, Confer A. 1991. Immunopotentiation of cattle vaccinated with a soluble Brucella abortus antigen with low LPS content: An analysis of cellular and humoral immune responses. Vet Microbiol 29:15-26.
12. Hilgers L, Snippe H. 1992. DDA as an immunological adjuvant. Res Immunol 143:494-503.
13. Kirby D, Rosenkrands I, Agger E, Andersen P, Coombes A, YP 2008. Liposomes act as stronger subunit vaccine adjuvants when compared to microspheres. J Drug Target 16:543-554.
14. Gall D. 1966. Adjuvant activity of aliphatic nitrogenous bases. Immunol Today 11:369-386.
15. Davidsen J, Rosenkrands I, Christensen D, Vangala A, Kirby D, Perrie Y, Agger E, Andersen P. 2005. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6, 6 dibehenate) a novel adjuvant inducing both strong CMI and antibody responses. Biochim Biophys Acta 1718:22-31.
16. Hilgers L, Snippe H, Jansze M, Willers J. 1985. Combinations of two synthetic adjuvants: synergistic effects of a surfactant and a polyanion on the humoral immune response. Cell Immunol 92:203-209.
17. Henriksen-Lacey M, Bramwell V, DC, Agger E-M, Andersen P, Perrie Y. 2010. Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen. J Control Release 142:180-186.
18. Dass C. 2004. Lipoplex-mediated delivery of nucleic acids: Factors affecting in vivo transfection. J Mol Med 82:579-591.
19. Garcia-Diaz Y, Wojno J, Cox L, Besra G. 2009. Synthesis of threitol ceramide and [14C] threitol ceramide, non-glycosidic analogues of the potent CD1 antigen a-galactosyl ceramide. Tetrahedron Asymmetry 20:747-753.
20. Christensen D, Kirby D, Foged C, Agger E, Andersen P, Perrie Y, Nielsen H. 2008. Alpha, alpha'-trehalose 6, 6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying. Biochim Biophys Acta 1778:1365-1373.
21. Lopes L, Scarpa M, Silva G, Rodrigues D, Santilli C, Oliveira A. 2004. Studies on the encapsulation of diclophenac in small unilamellar liposomes of soya phosphatidylcholine. Colloid Surf B Biointerfaces 39:151-158.
22. Schreier S, Malleiros S, de Paula E. 2000. Surface active drugs: Self-association and interaction with membranes and surfactants. Physicochemical and biological aspects. Biochim Biophys Acta 1508:210-234.
23. Kriwet K, Muller-Goymann C. 1994. Mutual interactions between diclofenac diethylamine and phospholipids-investigation on the microstructure of the arisen systems. Pharmazie 49:187-191.
24. Stoye I, Schroder K, Muller-Goymann C. 1998. Transformation of a liposomal dispersion containing ibuprofen lysinate and phospholipids into mixed micelles physicochemical characterization and influence on drug permeation through excised human stratum corneum. Eur J Pharm Biopharm 46:191-200.
25. Devaraj G, Parakh S, Devraj R, Apte S, Rao B, Rambhau D. 2002. Release studies on niosomes containing fatty alcohols as bilayer stabilisers instead of cholesterol. J Colloid Interf Sci 251:360-365.
26. Hac-Wydro K, Wydro P, Jagoda A, Kapusta J. 2007. The study on the interaction between phytosterols and phospholipids in model membranes. Chem Phys Lipids 150:22-34.
27. Andrade C, Santos-Magalhaes N, de Melo C. 2006. Thermodynamic characterization of the prevailing molecular interactions in mixed floating monolayers of phospholipids and usnic acid. J Colloid Interf Sci 298:145-153.
28. Chou T-H, Chang C-H. 2000. Thermodynamic behavior and relaxation processes of mixed DPPC:cholesterol monolayers at the air:water interface. Colloid Surf B Biointerfaces 17:71-79.
29. Gzyl B, Paluch M. 2005. Mixed monolayers of dipalmitoyl phosphatidylcholine and ethyl palmitate at the air/water interface. Appl Surf Sci 246:357-361.
30. Ali M, Kirby D, Mohammed A, Perrie Y. 2010. Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent. J Pharm Pharmacol 62:1646-1655.
31. Cardenas M, Nylander T, Jonsson B, Lindman B. 2005. The interaction between DNA and cationic lipid films at the air-water interface. J Colloid Interf Sci 286:166-175.
32. Hato M, Minamikawa H, Okamoto K, Iwahashi M. 1993. Monolayers of [omega] hydroxyalkyldimethyloctadecylammonium bromide at water-air interface. J Colloid Interf Sci 161:155-162.
33. Taylor D, Dong Y, Jones C. Thin Solid Films Seventh International Conference on Organized Molecular Films, 1996, 130-133.
34. Hac-Wydro K, Wydro P. 2007. The influence of fatty acids on model cholesterol/phospholipid membranes. Chem Phys Lipids 150:66-81.
35. Stanfield J, Gall D, Bracken P. 1973. Single-dose antenatal tetanus immunisation. Lancet 1:215-219.
36. Andersen P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 62:2536-2544.
37. van Rooij E, Glansbeek H, Hilgers L, Te Lintelo E, De Visser Y, Boersma W, Haagmans B, Bianchi A. 2002. Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant. J Virol 76:10540-10545.